EuropaBio, the European biotech industry association, has publicly welcomed the report IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy, released by the UK’s Department for Business Enterprise and Regulatory Reform (BERR).

The biotech industry has applauded the report which is in line with the EU’s Lead Market Initiative for Biobased Products and embraces EuropaBio’s policy recommendations developed to help the EU realise the vision of a Knowledge-Based Bio-Economy (KBBE).

Dirk Carrez, EuropaBio’s director of industrial biotechnology, said: "A competitive European knowledge-based Bioeconomy can only be realised when the European Union and the member states put a coherent policy framework in place. What has been done in the UK will motivate the industry to continue investment in this emerging and innovative industrial sector.”

Over the last two years, the biotech industry has supported the European Commission to work out a set of concrete steps to realise the vision of a Knowledge-Based Bio-Economy (KBBE), where biotechnology's new, clean, energy-efficient processes and innovative bio-based products create a sustainable industrial base to ensure Europe's future prosperity.

Willy De Greef, EuropaBio’s secretary general, said: “EuropaBio is pleased to note the support these recommendations have received from the UK government. Developing an innovation-driven economy is at the core of the Lisbon partnership. It is only with support of the member states that the vision to support growth and jobs in Europe by stimulating innovation can be realised.”